CHARGED ALPHATMFrontier AI stock research

MOH · NYSE

Molina Healthcare

Healthcare Plans · United States

USD 194.140.0% daily changeQuote 2026-10-06 · USD
Market cap (USD)
US$10.13B
Trailing P/E
2,157.11x
Forward P/E
19.92x
Quarterly revenue growth
-5.7%
Trailing net margin
-0.0%
Indicated dividend yield
—

Snapshot 2026-10-06 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.

Next earnings: 2026-10-21 (provider estimate, not issuer-confirmed).

Company background

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.

Company website

Q2 2026

Go beyond the headline.

Molina Healthcare (MOH) Stock: It Beat and RAISED Guidance — So Why Did It Crash 9%?

Published 2026-07-23

Comparable businesses

MOH peer comparison

Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.

Comparison stocks

Market metrics · missing or inapplicable values shown as —
MetricMOHMolina Healthcare, Inc.Snapshot 2026-10-06Financial period: 2026-06-30OSCROscar Health, Inc.Snapshot 2026-10-06Financial period: 2026-06-30CNCCentene CorporationSnapshot 2026-10-06Financial period: 2026-06-30
Market capMarket value, converted to USDUS$10.13BUS$9.99BUS$31.82B
Forward P/EProvider forward earnings estimate19.92x14.94x12.04x
EV / EBITDAEnterprise value / trailing EBITDA13.25x2.93x4.54x
Revenue growthLatest quarter vs prior-year quarter-5.7%70.4%4.6%
Operating marginLatest reported quarter1.4%8.0%3.8%
Free cash flow yieldTrailing cash flow / market cap6.9%6.9%30.3%
Net debt / EBITDANet debt / trailing EBITDA-12.72x-12.27x-2.38x
Debt / equityTotal debt / positive book equity0.95x0.23x0.71x
Trailing P/ETrailing twelve-month earnings2,157.11x25.09x—
Price / bookPrice / positive book equity per share2.42x4.86x1.41x
EV / salesEnterprise value / trailing revenue0.12x0.13x0.12x
Earnings growthLatest quarter vs prior-year quarter-75.3%——
Gross marginTrailing twelve months8.4%20.2%11.4%
Net marginTrailing twelve months-0.0%3.6%-2.8%
Return on equityProvider trailing return; positive equity only-0.2%34.3%-20.4%
Free cash flow marginTrailing free cash flow / revenue1.6%4.5%5.3%
Dividend yieldIndicated annual dividend / price———
Earnings payoutProvider trailing dividend payout0.0%0.0%0.0%
Current ratioCurrent assets / current liabilities1.68x1.08x1.15x
BetaProvider historical market sensitivity0.782.471.13

Choose a comparison stock

Search covered companies, or search all listed stocks.

Comparison methodology & limitations

Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.

Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.

Reported performance

Financial trends

Reporting period
Financial history
Chart style
Comparison stocks

Financial statements load separately from the research page.

Market context

Valuation & price history

Adjusted closing price

Price history

Price history loads separately.

Earnings-multiple scenario

Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.

Starting assumptions, when available, use provider forward estimates as of 2026-10-06. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.

THE RESEARCH RECORD

Research history for MOH

All available reporting periods
Q2 20262026-07-23
Q1 20262026-04-23
Deep Dive2026-04-23

Reported figures

Verify material figures against company filings. Market data and AI-assisted analysis may contain errors.